LumiSTAR is developing a pipeline of innovative cell therapies based on induced pluripotent stem cell (iPSC) technology. These therapies have the potential to revolutionize the treatment of a wide range of diseases, including neurodegenerative diseases such as Parkinson’s and Alzheimer’s, kidney failure and cancer.
Other than cell therapy, the company also equipped with iPSC and bioimaging-based high throughput drug screening platform to develop new drugs. The platform uses iPSC to create disease models for drug discovery and screening, allowing for more accurate and efficient identification of potential drug candidates.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Rm. 524, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei City,115,taiwan, Province Of China
- Industry
- Biotechnology
- Website
- lumistar.com.tw
- Keywords
- High throughput drug screening, Pre-clinical research, Induced pluripotent stem cell (iPSC) technology, Optogenetic tools, Machine learning for phenotypic screening, Organs-on-chips for personalized medicine, Customized screening platform, Genetically encoded tools, iPSC Cell Therapy.
- HQ
- Taipei City
Lumistar Biotechnology, Inc. 昱星生物科技 Questions
Lumistar Biotechnology, Inc. 昱星生物科技's website is lumistar.com.tw
Lumistar Biotechnology, Inc. 昱星生物科技's LinkedIn profile is https://tw.linkedin.com/company/lumistar-biotechnology
Lumistar Biotechnology, Inc. 昱星生物科技 has
15 employees.
View email and phone details for 15
employees at Lumistar Biotechnology, Inc. 昱星生物科技.
Lumistar Biotechnology, Inc. 昱星生物科技's industry is
Biotechnology
Lumistar Biotechnology, Inc. 昱星生物科技's top competitors are
Mesoview Co. Ltd.,
Global Bio & Investment Monthly,
Geneonline,
V5med Inc.,
Aivita Health Group,
Phytohealth Corporation 懷特生技新藥,
Caliway Biopharmaceuticals,
向榮生技unicocell Biomed,
Molecular Devices,
Celltech Accelerator.
Lumistar Biotechnology, Inc. 昱星生物科技's categories are Biotechnology
Lumistar Biotechnology, Inc. 昱星生物科技's founding year is 2016
